Aspirin 75mg gastro-resistant tablets

País: Regne Unit

Idioma: anglès

Font: MHRA (Medicines & Healthcare Products Regulatory Agency)

ingredients actius:

Aspirin

Disponible des:

Dexcel-Pharma Ltd

Codi ATC:

B01AC06

Designació comuna internacional (DCI):

Aspirin

Dosis:

75mg

formulario farmacéutico:

Gastro-resistant tablet

Vía de administración:

Oral

clase:

No Controlled Drug Status

tipo de receta:

Valid as a prescribable product

Resumen del producto:

BNF: 02090000

Informació per a l'usuari

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
ASPIRIN 75MG GASTRO-RESISTANT TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
This medicine is available without prescription. However, you still
need to use Aspirin 75mg Gastro-Resistant Tablets carefully to
get the best results from it. Always take this medicine exactly as
described in this leaflet or as your doctor or pharmacist has told
you.
• Keep this leaflet. You may need to read it again.
• Ask your pharmacist if you need more information or advice.
• If you get any side effects, talk to your doctor, pharmacist or
nurse. This includes any possible side effects not listed in this
leaflet. See section 4.
• You must talk to a doctor if you do not feel better or if you feel
worse.
WHAT IS IN THIS LEAFLET
1. What Aspirin 75mg Gastro-Resistant Tablets is and what
it is used for
2. What you need to know before you take Aspirin 75mg
Gastro-Resistant Tablets
3. How to take Aspirin 75mg Gastro-Resistant Tablets
4. Possible side effects
5. How to store Aspirin 75mg Gastro-Resistant Tablets
6. Contents of the pack and other information
1. WHAT ASPIRIN 75MG GASTRO-RESISTANT TABLETS IS AND
WHAT IT IS USED FOR
• Aspirin belongs to a group of medicines called antiplatelet
agents that help prevent your blood cells sticking together
and forming a blood clot.
• Aspirin 75mg Tablets are principally used to prevent blood
clots forming following a heart attack or stroke or to help
prevent heart attacks and strokes in patients who have
previously suffered from these conditions. They may have
been prescribed for you if you have recently had by-pass
surgery.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ASPIRIN 75MG
GASTRO-RESISTANT TABLETS
Do not take Aspirin 75mg Gastro-Resistant Tablets:
• if you are allergic to any of the ingredients of this medicine
(listed in section 6)
• if you are allergic to other salicylates or non-steroidal anti-
inflammatory drugs (NSAIDs). NSAIDs are often used f

Fitxa tècnica

OBJECT 1
Aspirin 75mg Gastro-Resistant Tablets
Summary of Product Characteristics Updated 26-Aug-2021 | Dexcel Pharma
Ltd
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Aspirin 75mg Gastro-Resistant Tablets
2. Qualitative and quantitative composition
Each tablet contains aspirin 75 mg.
Also includes 17mg/tablet lactose.
For the full list of excipients, see 6.1.
3. Pharmaceutical form
Gastro-resistant tablet.
White, film coated, round tablet.
4. Clinical particulars
4.1 Therapeutic indications
For the secondary prevention of thrombotic cerebrovascular or
cardiovascular disease and following by-pass
surgery.
4.2 Posology and method of administration
Posology
For the management of cardiovascular or cerebrovascular disease:
Patients should seek the advice of a doctor before commencing therapy
for the first time.
The usual dosage, for long-term use, is 75mg-150mg once daily. In some
circumstances a higher dose may
be appropriate, especially in the short term, and up to 300mg